Skip to main content
Download PDF
Download ePub

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Journal of Experimental & Clinical Cancer Research volume 42, Article number: 321 (2023) Cite this article

The Original Article was published on 21 June 2016

Correction: J Exp Clin Cancer Res 35, 99 (2016)

https://doi.org/10.1186/s13046-016-0372-5

Following publication of the original article [1], author found errors in Fig. 7, specifically:

  • Fig. 7d – the result of flow cytometry assay in Tet-shRNA + Dox group was misplaced

  • Fig. 7f – the results of flow cytometry assay in Tet-shRNA –Dox group and Tet-NC–Dox group were misplaced

Fig. 7
figure 1

Transfection with si-HOXD-AS1 or tet shRNA induced apoptosis in 5637 and T24. a-c The rate of early apoptotic 5637 (P = 0.001) and T24 cells (P < 0.001) were increased significantly after transfection with si-HOXD-AS1. d-g Increased apoptotic cells were observed in tet-shRNA-transfected 5637 (P = 0.001) and T24 cells (P < 0.001). Results represent the mean ± SD from three independent experiments

Full size image

The corrected Fig. 7 is given here. The correction does not affect the conclusions of the article.

Reference

  1. Li J, Zhuang C, Liu Y, et al. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. J Exp Clin Cancer Res. 2016;35:99. https://doi.org/10.1186/s13046-016-0372-5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Jianfa Li, Chengle Zhuang, Yuchen Liu and Mingwei Chen contributed equally to this work.

Authors and Affiliations

  1. Guangdong Province, Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People’s Hospital, Clinical Institute of Shantou University Medical College, First Affiliated Hospital of Shenzhen University, Shenzhen, 518039, People’s Republic of China

    Jianfa Li, Chengle Zhuang, Yuchen Liu, Mingwei Chen, Zhicong Chen, Anbang He, Junhao Lin, Yonghao Zhan, Li Liu, Wen Xu, Hanwei Wu, Zhiming Cai & Weiren Huang

  2. Guangdong Province, Shantou University Medical College, Shantou, 515041, People’s Republic of China

    Jianfa Li, Chengle Zhuang, Yincong Chen, Zhicong Chen, Junhao Lin, Yonghao Zhan, Li Liu, Zhiming Cai & Weiren Huang

  3. Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen, Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, 518036, People’s Republic of China

    Chengle Zhuang

  4. Anhui Province People’s, Anhui Medical University, Hefei, 230000, Republic of China

    Mingwei Chen, Anbang He, Zhiming Cai & Weiren Huang

  5. Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, 200000, People’s Republic of China

    Guoping Zhao

  6. Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, 100034, People’s Republic of China

    Yinglu Guo, Zhiming Cai & Weiren Huang

Authors
  1. Jianfa Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chengle Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuchen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mingwei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yincong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhicong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anbang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junhao Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yonghao Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Wen Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Guoping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yinglu Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Hanwei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Zhiming Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Weiren Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhiming Cai or Weiren Huang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Zhuang, C., Liu, Y. et al. Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. J Exp Clin Cancer Res 42, 321 (2023). https://doi.org/10.1186/s13046-023-02908-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-023-02908-6

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us